Gregory J. Divis
Chief Executive Officer, Director · AVADEL PHARMACEUTICALS PLC
- 2024
- Feb 12, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Gregory J. Divis files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Weiss Asset Management LP - $233.35M in AVDL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Gregory J. Divis?
Gregory J. Divis is a corporate insider, tracked as Chief Executive Officer, Director of AVADEL PHARMACEUTICALS PLC (AVDL). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Gregory J. Divis last file a Form 4?
The most recent primary Form 4 on record is dated 12 February 2026, one of 2 filings going back to 2024.
Has Gregory J. Divis been buying or selling stock?
Recorded transactions: 2 open-market purchases ($100K) and 0 open-market sales across all tracked filings.
